Ductal Carcinoma In Situ: A Rose by Any Other Name
Open Access
- 25 September 2013
- journal article
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 105 (20) , 1521-1522
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Treatment of Ductal Carcinoma In Situ After Excision: Would a Prophylactic Paradigm Be More Appropriate?JNCI: Journal of the National Cancer Institute, 2013
- The transition from ductal carcinoma in situto invasive breast cancer: the other side of the coinBreast Cancer Research, 2009
- Prospective Study of Wide Excision Alone for Ductal Carcinoma in Situ of the BreastJournal of Clinical Oncology, 2006
- Do Myoepithelial Cells Hold the Key for Breast Tumor Progression?Journal of Mammary Gland Biology and Neoplasia, 2005
- Trends in the Treatment of Ductal Carcinoma In Situ of the BreastJNCI: Journal of the National Cancer Institute, 2004
- Gene expression profiles of human breast cancer progressionProceedings of the National Academy of Sciences, 2003
- Molecular markers in ductal carcinoma in situ of the breast.2003
- Tumour markers in breast carcinoma correlate with grade rather than with invasivenessBritish Journal of Cancer, 2001
- Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trialThe Lancet, 1999
- Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic LociJNCI: Journal of the National Cancer Institute, 1998